Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a serious complication affecting up to half of people with scleroderma, and it’s a leading cause of death. New guidelines and ...

Rosalind Franklin University of Medicine and Science announced today that BLR Bio, a company in its Helix 51 incubator, ...

May is National Cancer Research Month a time to highlight the vital importance of scientific research in saving lives for ...

First Tracks Biotherapeutics, spun off from AnaptysBio, launches with $180M cash and a diverse, early-stage pipeline. Read ...

On Tuesday, Cumberland (NASDAQ: CPIX) discussed first-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call ...

About 8% of people in the United States live with an autoimmune disease, a condition in which the immune system mistakenly ...

Researchers are making strides in treating autoimmune diseases with cancer treatments. Lupus, multiple sclerosis & other ...

Researchers are looking into whether a breakthrough cancer therapy is the missing piece that could treat autoimmune diseases.

Most patients with systemic sclerosis require treatment with multiple modes of action, according to a presenter at Congress ...

BLR Bio LLC has presented new data highlighting the potential of BLR-200 for the treatment of systemic sclerosis (scleroderma). The company also presented data on its research on CCN proteins as ...

Take a Pest Control Quiz. Get matched with an Authorized Partner. Termites are more than just a nuisance — a termite infestation, if left untreated, can lead to costly repairs and compromise the ...